Allspring Global Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Allspring Global Investments's JAZZ Position: Q2 2026 in Review
Allspring Global Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 6.4% in Q2 2026, buying an estimated $42.7K and bringing the position to 3,229 shares worth $767K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.
Allspring Global Investments first reported a position in JAZZ in Q4 2021 and has held it in 19 quarters since. The position peaked at $20.5M in Q4 2022. 649 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Allspring Global Investments held 3,229 shares of Jazz Pharmaceuticals worth $767K as of Q2 2026.
- Allspring Global Investments bought 195 Jazz Pharmaceuticals shares in Q2 2026, an estimated $42.7K.
- Jazz Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1322 holding.
- Allspring Global Investments first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's Jazz Pharmaceuticals position peaked at $20.5M in Q4 2022.
- 649 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.